Literature DB >> 24238877

Cruciferous vegetables, glutathione S-transferase polymorphisms, and the risk of colorectal cancer among Chinese men.

Emily Vogtmann1, Yong-Bing Xiang2, Hong-Lan Li2, Quiyin Cai3, Qi-Jun Wu2, Li Xie2, Guo-Liang Li3, Gong Yang3, John W Waterbor4, Emily B Levitan4, Bin Zhang5, Wei Zheng3, Xiao-Ou Shu6.   

Abstract

PURPOSE: To assess the associations between cruciferous vegetable (CV) intake, GST gene polymorphisms, and colorectal cancer (CRC) in a population of Chinese men.
METHODS: Using incidence density sampling, CRC cases (N = 340) diagnosed before December 31, 2010 within the Shanghai Men's Health Study were matched to noncases (N = 673). CV intake was assessed from a food frequency questionnaire and by isothiocyanate levels from spot urine samples. GSTM1 and GSTT1 were categorized as null (0 copies) versus non-null (1 or 2 copies). Conditional logistic regression was used to calculate odds ratios and 95% confidence intervals for the association between CV intake and GST gene variants with CRC, and statistical interactions were evaluated.
RESULTS: CRC risk was not associated with CV intake, whether measured by self-report or by urinary isothiocyanate nor with GST gene variants. No statistical interactions were detected between CV intake and GST gene variants on the odds of CRC. Stratifying by timing of urine sample collection and excluding CRC cases diagnosed in the first 2 years did not materially alter the results.
CONCLUSIONS: This study provides no evidence supporting the involvement of CV intake in the development of CRC in Chinese men.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Brassicaceae; China; Colorectal neoplasms; Glutathione S-transferase M1; Glutathione S-transferase T1; Men

Mesh:

Substances:

Year:  2013        PMID: 24238877      PMCID: PMC3864981          DOI: 10.1016/j.annepidem.2013.10.003

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  26 in total

1.  Vegetable, fruit and meat consumption and potential risk modifying genes in relation to colorectal cancer.

Authors:  Faye Turner; Gillian Smith; Christoph Sachse; Tracy Lightfoot; R Colin Garner; C Roland Wolf; David Forman; D Timothy Bishop; Jennifer H Barrett
Journal:  Int J Cancer       Date:  2004-11-01       Impact factor: 7.396

Review 2.  Epigenetic impact of dietary isothiocyanates in cancer chemoprevention.

Authors:  Clarissa Gerhauser
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2013-07       Impact factor: 4.294

3.  Plasma creatinine determination. A new and specific Jaffe reaction method.

Authors:  C Slot
Journal:  Scand J Clin Lab Invest       Date:  1965       Impact factor: 1.713

4.  Urinary isothiocyanate levels and lung cancer risk among non-smoking women: a prospective investigation.

Authors:  Jay H Fowke; Yu-Tang Gao; Wong-Ho Chow; Qiuyin Cai; Xiao-Ou Shu; Hong-Lan Li; Bu-Tian Ji; Nat Rothman; Gong Yang; Fung-Lung Chung; Wei Zheng
Journal:  Lung Cancer       Date:  2010-11-30       Impact factor: 5.705

5.  Interplay between dietary inducers of GST and the GSTM-1 genotype in colon cancer.

Authors:  M L Slattery; E Kampman; W Samowitz; B J Caan; J D Potter
Journal:  Int J Cancer       Date:  2000-09-01       Impact factor: 7.396

6.  Dietary intake and colon cancer: sex- and anatomic site-specific associations.

Authors:  D W West; M L Slattery; L M Robison; K L Schuman; M H Ford; A W Mahoney; J L Lyon; A W Sorensen
Journal:  Am J Epidemiol       Date:  1989-11       Impact factor: 4.897

7.  Cruciferous vegetables intake and the risk of colorectal cancer: a meta-analysis of observational studies.

Authors:  Q J Wu; Y Yang; E Vogtmann; J Wang; L H Han; H L Li; Y B Xiang
Journal:  Ann Oncol       Date:  2012-12-04       Impact factor: 32.976

8.  Metabolism of sinigrin (2-propenyl glucosinolate) by the human colonic microflora in a dynamic in vitro large-intestinal model.

Authors:  Cyrille Krul; Christèle Humblot; Catherine Philippe; Martijn Vermeulen; Marleen van Nuenen; Robert Havenaar; Sylvie Rabot
Journal:  Carcinogenesis       Date:  2002-06       Impact factor: 4.944

9.  Common polymorphisms in GSTM1, GSTT1, GSTP1, GSTA1 and susceptibility to colorectal cancer in the Central European population.

Authors:  Renata Hezova; Julie Bienertova-Vasku; Milana Sachlova; Veronika Brezkova; Anna Vasku; Marek Svoboda; Lenka Radová; Igor Kiss; Rostislav Vyzula; Ondrej Slaby
Journal:  Eur J Med Res       Date:  2012-06-14       Impact factor: 2.175

10.  Dietary isothiocyanates, glutathione S-transferase polymorphisms and colorectal cancer risk in the Singapore Chinese Health Study.

Authors:  Adeline Seow; Jian-Min Yuan; Can-Lan Sun; David Van Den Berg; Hin-Peng Lee; Mimi C Yu
Journal:  Carcinogenesis       Date:  2002-12       Impact factor: 4.944

View more
  5 in total

1.  Gene-diet interactions and their impact on colorectal cancer risk.

Authors:  Elizabeth D Kantor; Edward L Giovannucci
Journal:  Curr Nutr Rep       Date:  2015-03

2.  GSTM1 polymorphism contribute to colorectal cancer in Asian populations: a prospective meta-analysis.

Authors:  Jing Li; Wen Xu; Fang Liu; Silin Huang; Meirong He
Journal:  Sci Rep       Date:  2015-07-29       Impact factor: 4.379

Review 3.  Role of Urinary Biomarkers in the Diagnosis of Adenoma and Colorectal Cancer: A Systematic Review and Meta-Analysis.

Authors:  Emma Altobelli; Paolo Matteo Angeletti; Giovanni Latella
Journal:  J Cancer       Date:  2016-10-08       Impact factor: 4.207

4.  Phytochemically rich dietary components and the risk of colorectal cancer: A systematic review and meta-analysis of observational studies.

Authors:  Pia Borgas; Guadalupe Gonzalez; Kirill Veselkov; Reza Mirnezami
Journal:  World J Clin Oncol       Date:  2021-06-24

5.  A novel strategy to block mitotic progression for targeted therapy.

Authors:  Junlong Jack Chi; Hongchun Li; Zhuan Zhou; Javier Izquierdo-Ferrer; Yifan Xue; Cindy M Wavelet; Gary E Schiltz; Bin Zhang; Massimo Cristofanilli; Xinghua Lu; Ivet Bahar; Yong Wan
Journal:  EBioMedicine       Date:  2019-10-25       Impact factor: 8.143

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.